Switch to:
St Jude Medical Inc (NYSE:STJ)
Research and Development
$718 Mil (TTM As of Jun. 2016)

This is the expense the company spent on research and development. St Jude Medical Inc's research and development for the three months ended in Jun. 2016 was $192 Mil. Its research and development for the trailing twelve months (TTM) ended in Jun. 2016 was $718 Mil.


Definition

This is the expense the company spent on research and development.

St Jude Medical Inc Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 was 161 (Sep. 2015 ) + 177 (Dec. 2015 ) + 188 (Mar. 2016 ) + 192 (Jun. 2016 ) = $718 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

St Jude Medical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Research & Development 431476532560643705676691692676

St Jude Medical Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
Research & Development 170178169175167171161177188192
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK